Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Single and Multiple Dose Study to Evaluate Safety, Pharmacokinetics, and Treatment Effect of Intravitreal AVD-104 in Participants With Geographic Atrophy Secondary to Age-related Macular Degeneration

NCT05839041 is registered in ClinicalTrials.gov with Aviceda Therapeutics, Inc. as lead sponsor.

NCT NCT05839041
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05839041 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Single and Multiple Dose Study to Evaluate Safety, Pharmacokinetics, and Treatment Effect of Intravitreal AVD-104 in Participants With Geographic Atrophy Secondary to Age-related Macular Degeneration
Lead sponsor
Aviceda Therapeutics, Inc.
Phase
Phase 2
Overall status
Completed
Start date
May 2, 2023
Completion date
February 18, 2026
Enrollment
300 (actual)
Sites
56

Conditions

As the registry lists them; a condition with its own page is linked.

geographic atrophy of the macula, macular degeneration